Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Bad flu season getting worse; skyrocketing cases set state record- Manual for Tracking down the Nearby Business sectors and Marketplaces
- California officials warn against foraging wild mushrooms after deadly poisoning outbreak
- Top 20 Wellbeing and Wellness Applications for a Sound Way of life
- Fact Check: Some Bridge Photos Circulating Do NOT Show The Hongqi Bridge That Collapsed In Southwest China Nov. 11, 2025
- Our 10 favorite Space.com reader astronomy photos of 2025
- 7 Powerful Methods for forestalling Telephone Overheating: Keep Your Gadget Cool
- The most effective method to Perceive the Early Side effects of Cellular breakdown in the lungs
- Finding the Universe of Computer generated Reality: Individual Encounters
